| Ytd | 80.27% | |
| 1y | 66.75% |
| Open | 3.40 | Prev Close | 3.43 | Low | 3.30 | High | 3.45 | Mkt Cap | 482.76M |
| Vol | 236.13K | Avg Vol | 653.03K | EPS | -0.46 | P/E | -7.24 | Forward P/E | -8.95 |
| Beta | 0.45 | Short Ratio | 14.24 | Inst. Own | 68.95% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-06 | 50-d Avg | 2.34 | 200-d Avg | 1.93 | 1yr Est | 9.63 |
OABI News
U.S. stocks rose, Nasdaq Composite up 1%. Natera Inc (NTRA) shares jump 20.5% after strong Q2 result
Gainers AVITA Medical (NASDAQ:RCEL) stock rose 58.4% to $7.53 during Friday's regular session.
OmniAb, Inc. (OABI) Q2 2026 Earnings Call Transcript
OmniAb NASDAQ: OABI reported higher second-quarter revenue and a narrower net loss as milestone paym
OmniAb, Inc. (OABI) came out with a quarterly loss of $0.05 per share versus the Zacks Consensus Est
OmniAb (NASDAQ:OABI) raises FY2026 sales outlook from $28.000 million-$33.000 million to $32.000 mil
OmniAb (NASDAQ:OABI) reported quarterly losses of $(0.05) per share which beat the analyst consensus
EMERYVILLE, Calif.--(BUSINESS WIRE)---- $OABI #OABI--OmniAb, Inc. (NASDAQ: OABI), a provider of cutt
VERAXA Biotech AG (NASDAQ:VRXA, "VERAXA" or the ", Company", ))), an emerging leader
ZURICH, SWITZERLAND, July 27, 2026 -- VERAXA Biotech AG (NASDAQ: VRXA; "VERAXA" or the "Company"), a
EMERYVILLE, Calif.--(BUSINESS WIRE)---- $OABI #OABI--OmniAb, Inc. (NASDAQ: OABI), a provider of cutt
OmniAb, Inc. (NASDAQ: OABI), a provider of cutting-edge discovery research technology to enable the
EMERYVILLE, Calif.--(BUSINESS WIRE)--OmniAb, Inc. (NASDAQ:OABI), a provider of cutting-edge discover
OmniAb NASDAQ: OABI reported first-quarter 2026 results that management characterized as a “very str
OmniAb, Inc. (OABI) came out with a quarterly loss of $0.06 per share versus the Zacks Consensus Est
EMERYVILLE, Calif.--(BUSINESS WIRE)---- $OABI #OABI--OmniAb, Inc. (NASDAQ: OABI) today reported fina
EMERYVILLE, Calif.--(BUSINESS WIRE)---- $OABI #OABI--OmniAb, Inc. (NASDAQ: OABI) today announced tha
EMERYVILLE, Calif.--(BUSINESS WIRE)---- $OABI #OABI--OmniAb, Inc. (NASDAQ: OABI) will report financi
OmniAb, Inc. (NASDAQ: OABI - Get Free Report) CEO Matthew Foehr sold 19,244 shares of the business's
OmniAb, Inc. (OABI) Q4 2025 Earnings Call Transcript
OmniAb, Inc. (OABI) came out with a quarterly loss of $0.11 per share versus the Zacks Consensus Est
EMERYVILLE, Calif.--(BUSINESS WIRE)---- $OABI #OABI--OmniAb, Inc. (NASDAQ: OABI) today reported fina
OmniAb (NASDAQ: OABI - Get Free Report) is expected to be releasing its Q4 2025 results after the ma
EMERYVILLE, Calif.--(BUSINESS WIRE)---- $OABI #OABI--OmniAb, Inc. (NASDAQ: OABI) will report financi
OmniAb, Inc. (OABI) Discusses Launch and Scientific Overview of OmniUltra Technology Platform Transc
Companies Reporting Before The Bell • Indivior (NASDAQ:INDV) is expected to report quarterly earnin
Companies Reporting Before The Bell • IDEX Biometrics (NASDAQ:IDBA) is estimated to report quarterl
Companies Reporting Before The Bell • Takeda Pharmaceutical (NYSE:TAK) is likely to report earnings
Companies Reporting Before The Bell • Creative Realities (NASDAQ:CREX) is estimated to report quart